DARWIN EU® is calling for new data partners

By Staff Writer

April 3, 2023

DARWIN EU®, a network for data analysis and real-world interrogation, has successfully completed its first year of operation. The network has onboarded ten data partners and initiated four studies using real-world data from across Europe to better understand diseases, populations, and the uses and effects of medicines. DARWIN EU® generates real-world evidence to support the decision-making of EMA scientific committees and national competent authorities in EU Member States throughout regulatory processes. The network plans to onboard ten additional data partners and initiate around 16 studies in 2023. The first four studies demonstrate the benefits of DARWIN EU®, including faster performance, increased capacity, and lower costs. Results from completed studies have been provided to relevant EMA committees to support their future work. DARWIN EU® is also collaborating with stakeholders and participating in a pilot for the European Health Data Space (EHDS), ultimately delivering around 150 RWE studies per year by 2025.

Reference url

Recent Posts

tuberculosis burden children
   

Tackling the Tuberculosis Burden in Children: A Global Perspective

🌍 Did you know the global burden of tuberculosis (TB) among children has dropped significantly over the past three decades?

Our recent analysis reveals a remarkable 37.4% reduction in TB incidence and a staggering 71.7% decrease in deaths from 1990 to 2021. Yet, challenges persist, especially in low SDI regions where this public health threat continues to expose disparities in healthcare access and outcomes.

Look into the full article to explore these critical insights and the implications for future strategies in TB management.

#SyenzaNews #globalhealth #HealthcareInnovation

dialysis technology innovations
    

Dialysis Technology Innovations: Revolutionizing Patient Care with Portable Solutions

🔍 Are we on the brink of a revolution in dialysis technology?

Recent innovations like the AKTIV and wearable kidneys promise to transform the bulky dialysis process into a more portable and efficient treatment. However, significant challenges remain, including funding and the dominance of large corporations that stifle innovation.

Dive into the full article to learn how these advancements could enhance patient quality of life and challenge the status quo in dialysis care.

#SyenzaNews #MedTech #HealthcareInnovation #innovation

chronic kidney disease burden
         

Rising Chronic Kidney Disease Burden: A Global Health Challenge from 1990 to 2021

🌍 Did you know that the burden of chronic kidney disease has significantly increased since 1990?

Our latest article dissects the findings from the Global Burden of Disease Study 2021, revealing stark trends in CKD incidence, mortality, and demographic disparities. With increasing healthcare costs and the urgent need for targeted interventions, it’s crucial to understand how to effectively address this growing public health challenge.

Dive into the insights and discover what innovative strategies can make a real difference!

#SyenzaNews #GlobalHealth #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.